A
Anuradha Lala
Researcher at Icahn School of Medicine at Mount Sinai
Publications - 155
Citations - 6472
Anuradha Lala is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Medicine & Heart failure. The author has an hindex of 31, co-authored 112 publications receiving 3528 citations. Previous affiliations of Anuradha Lala include Cardiovascular Institute of the South & Brigham and Women's Hospital.
Papers
More filters
Journal ArticleDOI
Heart Month - A Historical Look and Simple "Walk" of Acknowledgement in the Present.
Anuradha Lala,Robert J. Mentz +1 more
TL;DR: Johnson as mentioned in this paper declared the month of February as American Heart Month and urged the people of the United States to give heed to the nationwide problem of heart and blood-vessel diseases, and to support the programs required to bring about its solution.
Journal ArticleDOI
Outcomes of Simultaneous Heart and Kidney Transplantation.
Shinobu Itagaki,Nana Toyoda,Noah Moss,D.Joshua Mancini,Natalia N. Egorova,Takahisa Mikami,Erick Sun,Yuki Bekki,Gregory Serrao,Anuradha Lala,Percy Boateng,David H. Adams,Anelechi C. Anyanwu +12 more
TL;DR: In this article , the effects and utility of simultaneously implanted kidney allografts with various degrees of kidney dysfunction during heart transplantation was investigated and Multivariable Cox regression was used for risk adjustment.
Journal ArticleDOI
Recombinant Herpes Zoster Vaccine (RZV) after Heart Transplantation: A Single Center Experience
Maya H. Barghash,Sarah Taimur,Meenakshi Rana,J. Behar,Anuradha Lala,Sumeet S. Mitter,N. Moss,Sean Pinney,Donna M. Mancini +8 more
TL;DR: HT patients who received RZV tolerated it well with the most common AE being injection site soreness, and only one patient developed HZ 2 months following the vaccination, there was no evidence of increased allograft rejection.
Journal ArticleDOI
Use of Remote Dielectric Sensing (ReDS) as Point-of-Care Testing Following Heart Failure Hospitalization and Risk of 30-Day Readmission
Maya H. Barghash,Anuradha Lala,Gennaro Giustino,Aditya Parikh,J. Ullman,Sumeet S. Mitter,S. Konje,B. Keith,N. Moss,Donna M. Mancini,Maria Giovanna Trivieri,Johanna Contreras,Dan Burkhoff,Sean Pinney +13 more
TL;DR: Use of ReDS to guide GDMT and diuretic titration for HF was feasible and may be associated with lower 30-day readmission post-discharge for HF, and longitudinal experience with ReDS testing can provide insights into the frequency of congestion early after HF discharge, reductions in hospital readmission and the optimization of GDMT.
Journal ArticleDOI
JCF Heart Failure Year-In-Review 2022… The Best is Yet to Come!
TL;DR: A summary of key results for some of these practice-changing trials, while highlighting important initiatives and publications specific to our #JCFfamily, can be found in this article , where the authors also highlight the importance of heart failure research.